Heterogeneous effects of exogenous lymphokines on lymphoproliferation of elderly subjects.
Although the ability of peripheral blood mononuclear cells of a population of elderly subjects (mean age 85.3) to proliferate in response to the T cell mitogens phytohemagglutinin (PHA) and concanavalin A (Con A) is significantly reduced compared to young subjects (mean age 24.7), the response of the elderly subjects is heterogeneous. While 47% of the elderly subjects responded at about half the level of young controls, 15% responded at less than 20% the level and the remaining 38% responded comparably to young controls. Similar heterogeneity was observed in lymphokine production. However, there was no significant correlation between the level of proliferative response and production of either interleukin 2 (IL-2) or interferon gamma (IFN-g). In an effort to further explore the role of lymphokines in the decreased proliferative response of elderly subjects, various concentrations of exogenous IL-2 and/or IFN-gamma were added at the initiation of the mitogen stimulated cultures. Similar increases in both the level of response and the number of subjects demonstrating an increase was observed for both young and elderly subjects upon addition of either IL-2 or IFN-gamma. However, addition of a combination of IL-2 and IFN produced more pronounced effects in the elderly subjects. Approximately 1/3 of the elderly subjects who demonstrated decreased PHA-induced proliferation doubled their PHA induced proliferative response upon addition of a combination of lymphokines. The amounts of IL-2 and IFN-gamma required for this increase varied for each individual.(ABSTRACT TRUNCATED AT 250 WORDS)
Hessen
M T
MT
Department of Medicine, Medical College of Pennsylvania, Philadelphia 19129.
Kaye
D
D
Murasko
D M
DM
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology*; D003208:Concanavalin A / Q000494:pharmacology; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis; D007376:Interleukin-2 / Q000096:biosynthesis; D008213:Lymphocyte Activation / Q000187:drug effects*; D008222:Lymphokines / Q000096:biosynthesis / Q000494:pharmacology*; D010835:Phytohemagglutinins / Q000494:pharmacology
D007376:Interleukin-2; D008222:Lymphokines; D010835:Phytohemagglutinins; D003208:Concanavalin A; D007371:Interferon-gamma